155 related articles for article (PubMed ID: 38598007)
1. Preoperative nomogram for predicting spread through air spaces in clinical-stage IA non-small cell lung cancer using
Wang Y; Lyu D; Cheng C; Zhou T; Tu W; Xiao Y; Zuo C; Fan L; Liu S
J Cancer Res Clin Oncol; 2024 Apr; 150(4):185. PubMed ID: 38598007
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of CT and
Li H; Li L; Liu Y; Deng Y; Zhu Y; Huang L; Long T; Zeng L; Shu Y; Peng D
BMC Cancer; 2024 Apr; 24(1):434. PubMed ID: 38589832
[TBL] [Abstract][Full Text] [Related]
3. Nomogram based on clinical characteristics and radiological features for the preoperative prediction of spread through air spaces in patients with clinical stage IA non-small cell lung cancer: a multicenter study.
Wang Y; Lyu D; Zhang D; Hu L; Wu J; Tu W; Xiao Y; Fan L; Liu S
Diagn Interv Radiol; 2023 Nov; 29(6):771-785. PubMed ID: 37724737
[TBL] [Abstract][Full Text] [Related]
4. Multivariate analysis based on the maximum standard unit value of
Wang Y; Lyu D; Zhou T; Tu W; Fan L; Liu S
Diagn Interv Radiol; 2023 Mar; 29(2):379-389. PubMed ID: 36988049
[TBL] [Abstract][Full Text] [Related]
5. [Construction of A Nomogram Prediction Model for PD-L1 Expression
in Non-small Cell Lung Cancer Based on 18F-FDG PET/CT Metabolic Parameters].
Hao L; Wang L; Zhang M; Yan J; Zhang F
Zhongguo Fei Ai Za Zhi; 2023 Nov; 26(11):833-842. PubMed ID: 38061885
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a clinic-radiological model to predict tumor spread through air spaces in stage I lung adenocarcinoma.
Gao Z; An P; Li R; Wu F; Sun Y; Wu J; Yang G; Wang Z
Cancer Imaging; 2024 Feb; 24(1):25. PubMed ID: 38336821
[TBL] [Abstract][Full Text] [Related]
7. Mean computed tomography value to predict spread through air spaces in clinical N0 lung adenocarcinoma.
Yamamoto M; Tamura M; Miyazaki R; Okada H; Wada N; Toi M; Murakami I
J Cardiothorac Surg; 2024 Apr; 19(1):260. PubMed ID: 38654352
[TBL] [Abstract][Full Text] [Related]
8. Tumour standardized uptake value on positron emission tomography is a novel predictor of adenocarcinoma in situ for c-Stage IA lung cancer patients with a part-solid nodule on thin-section computed tomography scan.
Hattori A; Suzuki K; Matsunaga T; Fukui M; Tsushima Y; Takamochi K; Oh S
Interact Cardiovasc Thorac Surg; 2014 Mar; 18(3):329-34. PubMed ID: 24351509
[TBL] [Abstract][Full Text] [Related]
9. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.
Miyasaka Y; Suzuki K; Takamochi K; Matsunaga T; Oh S
Eur J Cardiothorac Surg; 2013 Jul; 44(1):83-7. PubMed ID: 23233074
[TBL] [Abstract][Full Text] [Related]
10. 18F FDG-PET/CT analysis of spread through air spaces (STAS) in clinical stage I lung adenocarcinoma.
Nishimori M; Iwasa H; Miyatake K; Nitta N; Nakaji K; Matsumoto T; Yamanishi T; Yoshimatsu R; Iguchi M; Tamura M; Yamagami T
Ann Nucl Med; 2022 Oct; 36(10):897-903. PubMed ID: 35829825
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a CT-based nomogram to predict spread through air space (STAS) in peripheral stage IA lung adenocarcinoma.
Chen Y; Jiang C; Kang W; Gong J; Luo D; You S; Cheng Z; Luo Y; Wu K
Jpn J Radiol; 2022 Jun; 40(6):586-594. PubMed ID: 35079955
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment prediction of tumour spread through air spaces in clinical stage I non-small-cell lung cancer.
Ding Y; Chen Y; Wen H; Li J; Chen J; Xu M; Geng H; You L; Pan X; Sun D
Eur J Cardiothorac Surg; 2022 Aug; 62(3):. PubMed ID: 35385066
[TBL] [Abstract][Full Text] [Related]
13. Metabolic characteristics of programmed cell death-ligand 1-expressing lung cancer on
Takada K; Toyokawa G; Okamoto T; Baba S; Kozuma Y; Matsubara T; Haratake N; Akamine T; Takamori S; Katsura M; Shoji F; Honda H; Oda Y; Maehara Y
Cancer Med; 2017 Nov; 6(11):2552-2561. PubMed ID: 28980429
[TBL] [Abstract][Full Text] [Related]
14. Combination of Fluorine-18 Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography (¹⁸F-FDG PET/CT) and Tumor Markers to Diagnose Lymph Node Metastasis in Non-Small Cell Lung Cancer (NSCLC): A Retrospective and Prospective Study.
Zhai X; Guo Y; Qian X
Med Sci Monit; 2020 Jun; 26():e922675. PubMed ID: 32483109
[TBL] [Abstract][Full Text] [Related]
15. The value on SUV-derived parameters assessed on
Liao X; Liu M; Li S; Huang W; Guo C; Liu J; Xiong Y; Zhang J; Fan Y; Wang R
BMC Med Imaging; 2023 Apr; 23(1):49. PubMed ID: 37020286
[TBL] [Abstract][Full Text] [Related]
16. 18F-FDG PET/CT and circulating tumor cells in treatment-naive patients with non-small-cell lung cancer.
Zhang F; Wu X; Zhu J; Huang Y; Song X; Jiang L
Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3250-3259. PubMed ID: 33630146
[TBL] [Abstract][Full Text] [Related]
17. Tumor-to-liver standard uptake ratio using fluorine-18 fluorodeoxyglucose positron emission tomography computed tomography effectively predict occult lymph node metastasis of non-small cell lung cancer patients.
Shi YM; Niu R; Shao XL; Zhang FF; Shao XN; Wang JF; Wang XS; Liu B; Yu WJ; Wang YT
Nucl Med Commun; 2020 May; 41(5):459-468. PubMed ID: 32187163
[TBL] [Abstract][Full Text] [Related]
18. New insight on the correlation of metabolic status on
Wang Y; Zhao N; Wu Z; Pan N; Shen X; Liu T; Wei F; You J; Xu W; Ren X
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1127-1136. PubMed ID: 31502013
[TBL] [Abstract][Full Text] [Related]
19. An [
Meng N; Feng P; Yu X; Wu Y; Fu F; Li Z; Luo Y; Tan H; Yuan J; Yang Y; Wang Z; Wang M
Eur Radiol; 2024 Jan; 34(1):318-329. PubMed ID: 37530809
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of multiple metabolic and heterogeneity parameters of
Shi A; Wang J; Wang Y; Guo G; Fan C; Liu J
Ann Nucl Med; 2022 Apr; 36(4):393-400. PubMed ID: 35084711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
